Journal article
Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?
Abstract
BACKGROUND: The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial enrolled patients from 3 distinct healthcare systems (HCSs) in North America. The primary aim of this study was to determine whether there is a treatment difference in cardiovascular outcomes by HCS.
METHODS AND RESULTS: The study population included 968 patients from the US Department of Veterans Affairs (VA), 386 from the US non-VA, …
Authors
Chaitman BR; Hartigan PM; Booth DC; Teo KK; Mancini GBJ; Kostuk WJ; Spertus JA; Maron DJ; Dada M; O'Rourke RA
Journal
Circulation Cardiovascular Quality and Outcomes, Vol. 3, No. 5, pp. 476–483
Publisher
Wolters Kluwer
Publication Date
9 2010
DOI
10.1161/circoutcomes.109.901579
ISSN
1941-7713